Bullish
$OMER the FDA granted Narso Breakthrough Status on Preliminary Data. FACT. DATA. Successful outcomes. No veils. DATA. It also granted a rolling BLA because the data was compelling . Not pipe dreams. Stanford Surgeons stood behind it. Compelling. Could it be a bust? Certainly. But I love the risk reward. Fence sitting liars should be called out for the shills they are. Place your bets - the Narso risk reward is VERY compelling. Omidria did it’s job - it’s gravy either way. Trolls who purport to know something they obviously dont should be derided or blocked - again, you choose.
  • 2